# Investigating the Gut Microbiota Modulation Effects of Allicin for Cardiovascular Disease Protection and Establishing Microbiota Directed Personalized Nutrition Guidance With Novel Humanized Gnotobiotic Mice Model, Microbial Culturomics and Metabolomic Technique

> **NCT04545879** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 9 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Raw garlic juice containing allicin

## Key facts

- **NCT ID:** NCT04545879
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2019-05-18
- **Final completion:** 2019-05-18
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04545879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04545879, "Investigating the Gut Microbiota Modulation Effects of Allicin for Cardiovascular Disease Protection and Establishing Microbiota Directed Personalized Nutrition Guidance With Novel Humanized Gnotobiotic Mice Model, Microbial Culturomics and Metabolomic Technique". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04545879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*